BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 7472582)

  • 1. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
    Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
    J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of viable myocardium using 99mTc-tetrofosmin scintigraphy--comparison with 201Tl redistribution-reinjection images].
    Kobayashi H; Kawaguchi M; Oka T; Inoue S; Handa J; Asano R; Matsumoto N; Sumiyoshi T; Hosoda S; Kusakabe K
    Kaku Igaku; 1995 Apr; 32(4):367-75. PubMed ID: 7776543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.
    Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M
    Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Tonami N; Hisada K
    Am J Cardiol; 1996 Feb; 77(5):350-4. PubMed ID: 8602561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 99Tcm-tetrofosmin myocardial perfusion scintigraphy in the assessment of patients with previous myocardial infarction: a comparative study with 201Tl.
    Burak Z; Akin H; Buket S; Sagcan A; Argon M; Atay Y; Durmaz I; Duman Y
    Nucl Med Commun; 1998 Feb; 19(2):127-36. PubMed ID: 9548196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.
    Nicolai E; Cuocolo A; Acampa W; Varrone A; Pace L; Salvatore M
    J Nucl Cardiol; 1999; 6(3):270-7. PubMed ID: 10385182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
    J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility.
    Bisi G; Sciagrà R; Santoro GM; Zerauschek F; Fazzini PF
    J Nucl Med; 1994 Aug; 35(8):1274-8. PubMed ID: 8046478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.
    Tamaki N; Takahashi N; Kawamoto M; Torizuka T; Tadamura E; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1994 Apr; 35(4):594-600. PubMed ID: 8151381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual cardiomyocytes and scintigraphic findings in advanced coronary artery disease: correlation with technetium-99m-tetrofosmin and thallium-201 single photon emission computed tomography.
    Fujino S; Matsunari I; Saga T; Okazaki H; Haraki T; Aoyama T; Hirai J; Doishita K; Takekoshi N
    Jpn Circ J; 1999 Jan; 63(1):64-7. PubMed ID: 10084392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease.
    Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T
    J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.
    Nakajima K; Taki J; Shuke N; Bunko H; Takata S; Hisada K
    J Nucl Med; 1993 Sep; 34(9):1478-84. PubMed ID: 8355067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
    Zaret BL; Rigo P; Wackers FJ; Hendel RC; Braat SH; Iskandrian AS; Sridhara BS; Jain D; Itti R; Serafini AN
    Circulation; 1995 Jan; 91(2):313-9. PubMed ID: 7805233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial perfusion tomography imaging in patients without prior myocardial infarction--comparison between 201Tl, 99mTc-tetrofosmin and dual-isotope protocol (rest 201Tl/stress 99mTc-tetrofosmin)].
    Kamínek M; Myslivecek M; Skvarilová M; Husák V; Lang O
    Vnitr Lek; 1999 Feb; 45(2):81-4. PubMed ID: 15641225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.